PBH — Prestige Consumer Healthcare Income Statement
0.000.00%
Last trade - 00:00- $2.28bn
- $3.24bn
- $1.09bn
Annual income statement for Prestige Consumer Healthcare, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,087 | 1,128 | 1,125 | 1,138 | 1,089 |
| Cost of Revenue | |||||
| Gross Profit | 621 | 625 | 624 | 634 | 596 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 759 | 1,150 | 783 | 801 | 779 |
| Operating Profit | 328 | -22.4 | 342 | 337 | 309 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 262 | -93.9 | 276 | 284 | 257 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 205 | -82.3 | 209 | 215 | 190 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 205 | -82.3 | 209 | 215 | 190 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 205 | -82.3 | 209 | 215 | 190 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.08 | 3.24 | 4.17 | 4.47 | 4.06 |